James Foster
Foot & Ankle Surgery · Columbus, OHNPI 1376961656
Payments from drug & device makers
Across 85 payments — averaging $46.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CDC Medical LLC$2K
- Smith+Nephew$646
- Nevro Corp.$206
- Paratek Pharmaceuticals, Inc.$167
- Amgen$147
- Nabriva Therapeutics, PLC$63
- plus $400 from 17 others
What the payments were for
- Food & beverage$1,62841%
- Education$2,35859%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CDC Medical LLC | 2 | $2,358 |
| Smith+Nephew | 36 | $646 |
| Nevro Corp. | 7 | $206 |
| Paratek Pharmaceuticals, Inc. | 9 | $167 |
| Amgen(2 entities) | 9 | $147 |
| Nabriva Therapeutics, PLC | 4 | $63 |
| Polynovo North America LLC | 1 | $54 |
| Medtronic | 2 | $34 |
| Encore Medical, LP | 1 | $30 |
| Zimmer Biomet | 1 | $30 |
| Johnson & Johnson | 1 | $29 |
| Stability Biologics, LLC | 1 | $23 |
| Aroa Biosurgery Incorporated | 1 | $23 |
| Cashflow Solutions, LLC | 1 | $22 |
| Triad Life Sciences Inc. | 1 | $21 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $20 |
| Avanos Medical | 1 | $19 |
| Abbott | 1 | $19 |
| Stryker | 1 | $16 |
| Inari Medical, Inc. | 1 | $16 |
| Averitas Pharma Inc. | 1 | $15 |
| Paragon 28, Inc. | 1 | $14 |
| Mimedx Group, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Stravix$106
How this compares
$3,986 in reported general payments places this provider in the 55th percentile of 429 foot & ankle surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 24 | $212 |
| Clindamycin Hcl | 13 | $49 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Columbus
- Jeffrey GittinsColumbus$186K
- Randall ThomasColumbus$93K
- Animesh BhatiaColumbus$46K
- Richard WeinerColumbus$18K
- Christopher HyerWorthington$4.9M
- Thomas LeePickerington$4M
- Jordan GrossmanAkron$2.5M
- Robert GorslineHilliard$1.4M
- Jonathan FeibelGahanna$1.4M
- Mark PrisselWorthington$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.